Dublin, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The "Continuous Manufacturing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Continuous ...

Smart manufacturing & advanced pharmaceuticals to shape the future by 2030: Kaushik Desai: Nandita Vijayasimha Bengaluru Wednesday, December 17, 2025, 08:00 Hrs [IST] By 2030, the ...

More and more drugmakers are giving continuous manufacturing a try, seeing it as the future in small molecule drug production, in part, because the plants for the process are much smaller than those ...

Continuous manufacturing makes monoclonal antibody production faster, cheaper, and greener, say researchers, who predict that industry adoption of the approach will accelerate in response to ...

A handful of companies have done pioneering work with continuous manufacturing, the production process that is faster, cheaper and less prone to the kinds of manufacturing mess-ups that worry the FDA.

New York, March 10, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Continuous Manufacturing Market : Industry Trends and Global ...

DIANT is a startup co-founded by Antonio Costa, Ph.D. and Diane Burgess, Ph.D. In 2020, DIANT licensed their core manufacturing technology from UConn and was granted a patent on the technology earlier ...

The pharmaceutical industry has been slow to adopt a business practice that is faster, safer, and more efficient than its current way of operating; that the FDA has been encouraging the industry to ...

Although estimates vary slightly, many industry experts predict continuous manufacturing will, at the least, cut the cost of manufacturing biologics in half. Thus, it will be an attractive option for ...

Continuous pharmaceutical manufacturing represents a significant shift from traditional batch processing, integrating continuous flow methods, advanced process analytical technology (PAT) and ...

The biopharmaceutical industry has seen substantial growth in recent years, generating novel biotherapeutics and biosimilars at an unprecedented rate. One of the biggest challenges in the industry is ...

Nick Pinchuk, president and CEO of Snap-on (IW 500/271), wields continuous improvement as a weapon, a weapon against the turbulent manufacturing climate, a weapon against the dwindling middle class, ...